Test code: 16377

CPT code(s): 87493

Methodology: Real Time Polymerase Chain Reaction (PCR)

Clinical Significance: C. difficile is the major cause of antibiotic-associated diarrhea (AAD) and pseudomembranous colitis.

Alternative Names: C. difficile Toxin B Gene; C. diff PCR

Basic Metabolic Panel with eGFR

Test Code: 10165
CPT Code(s): 80048
Includes: BUN/Creatinine Ratio (calculated), Calcium, Carbon Dioxide, Chloride, Creatinine with GFR Estimated, Glucose, Potassium, Sodium, Urea Nitrogen (BUN)
Alternative Name(s): Basic MET, Basic Metabolic, BMP, BMP w/ EGFR, BMP with EGFR, CHEM panel, Limited Metabolic, LMP, Metabolic Panel

CBC (Hemoglobin/Hematocrit, RBC, Indices, WBC, Platelet) – without the Differential

Test Code: 1759
CPT Code: 85027
Includes: WBC, RBC, Hemoglobin, Hematocrit, MCV, MCH, MCHC, RDW, Platelet Count

Test Code: 4606

CPT Code(s): 87103, 87106, 87107, 87143, 87149

Includes: If culture is positive, identification will be performed at an additional charge (CPT code(s): 87106 or 87107 or 87140 or 87143 or 87149 or 87158).

The CPT codes provided are based on ama guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.

BRCAvantage™ Plus (BRCA1, BRCA2, TP53, PTEN, CDH1, STK11, PALB2)

Test Code: 92587

CPT Code(s): 81162, 81405 (x2), 81479, 81321, 81323, 81406 (x2), 81404

Methodology: Exon Capture • Next Generation Sequencing • Multiplex Ligation-dependent Probe Amplification (MLPA)

BRCAvantage™ Comprehensive

Test Code: 91863

CPT Code(s): 81162

Supply: 193292 Lavender 4mL Blood Tube

Includes:
BRCA1 Sequencing, BRCA1 Deletion/Duplication, BRCA2 Sequencing, BRCA2 Deletion/Duplication, Comprehensive Interpretation

Methodology:
Next Generation Sequencing • Multiplex Ligation-dependent Probe Amplification (MLPA)

Reference Range(s): See Laboratory Report

Bacterial Vaginosis/Vaginitis Panel

Test Code: 14577

CPT Code(s): 87480, 87510, 87660

Includes: Candida species, Trichomonas vaginalis, Gardnerella vaginalis

Methodology: DNA Probe

Special Instructions: Cervical specimens should be avoided because of the effect of elevated sialidase activity. Specimens should not be collected from a patient who has used any vaginal product in the previous 72 hours, e.g., cream, gel, spermicide, or douching.

Test Code: 11363

Includes: Chlamydia trachomatis, Neisseria gonorrhoeae

Methodology: Dual Kinetic Assay (DKA) • Target Capture • Transcription-Mediated Amplification (TMA)

Reference Range(s):
C.trachomatis RNA, TMA - Not detected
N.gonorrhoeae RNA, TMA - Not detected

This test was performed using the APTIMA^® COMBO2 Assay (GEN-PROBE).

Test Code: 11363

Includes: Chlamydia trachomatis, Neisseria gonorrhoeae

Methodology: Dual Kinetic Assay (DKA) • Target Capture • Transcription-Mediated Amplification (TMA)

Reference Range(s):
C.trachomatis RNA, TMA - Not detected

N.gonorrhoeae RNA, TMA - Not detected

This test was performed using the APTIMA® COMBO2 Assay (GEN-PROBE).

Test code: 394

CPT code(s): 87070

Includes: If culture is positive, identification will be performed at an additional charge (CPT code(s): 87077 or 87140 or 87143 or 87147 or 87149).
Antibiotic susceptibilities are only performed when appropriate (CPT code(s): 87181 or 87184 or 87185 or 87186).

Methodology: Bacterial culture, Aerobic routine isolation and Identification procedures; Antibiotic susceptibility testing (when appropriate)